Hyperlipidemia as adverse event of lorlatinib, a multicenter cohort study.

Authors: Fei Xu, Yuan Cheng, Yan Wang, Tao Xin, Bo Jin, Jian Fang, Li Liang, Xiaoyan Li, Chuanhao Tang, Yonggang Liu, Huijuan Cui, Dong Yan, Lin Li, Yuhui Zhang, Li Zhang, Yunzhi Zhou, Xin Lin Mu

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e24040

Source: Full article

---

Abstract

e24040